Advanced search
Publication Cover
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Volume 23, 2022 - Issue 1-2
Submit an article Journal homepage
1,887
Views
3
CrossRef citations to date
0
Altmetric
Clinical

Evidence for generalizability of edaravone efficacy using a novel machine learning risk-based subgroup analysis tool

Benjamin Rix Brooks1 Carolinas Neuromuscular/ALS-MDA Care Center, Charlotte, NC, USAView further author information
,
Erik P. Pioro2 Section of ALS & Related Disorders, Cleveland Clinic, Cleveland, OH, USAView further author information
,
Danielle Beaulieu3 Origent Data Sciences, Inc., Vienna, VA, USA, andView further author information
,
Albert A. Taylor3 Origent Data Sciences, Inc., Vienna, VA, USA, andView further author information
,
Mark Schactman3 Origent Data Sciences, Inc., Vienna, VA, USA, andView further author information
,
Mike Keymer3 Origent Data Sciences, Inc., Vienna, VA, USA, andView further author information
,
Wendy Agnese4 Mitsubishi Pharma America, Inc., Jersey City, NJ, USAView further author information
,
Johnna Perdrizet4 Mitsubishi Pharma America, Inc., Jersey City, NJ, USAView further author information
,
Stephen Apple4 Mitsubishi Pharma America, Inc., Jersey City, NJ, USACorrespondence[email protected]
View further author information
&
David L. Ennist3 Origent Data Sciences, Inc., Vienna, VA, USA, andView further author information
 show all
Pages 49-57 | Received 27 Oct 2020, Accepted 25 Apr 2021, Published online: 10 Jul 2021

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Gary L. Pattee, Angela Genge, Philippe Couratier, Christian Lunetta, Gen Sobue, Masashi Aoki, Hiide Yoshino, Carlayne E. Jackson, James Wymer, Alejandro Salah & Sally Nelson. (2023) Oral Edaravone – Introducing a Flexible Treatment Option for Amyotrophic Lateral Sclerosis. Expert Review of Neurotherapeutics 0:0, pages 1-8.
Read now

Articles from other publishers (2)

Christina N. Fournier. (2022) Considerations for Amyotrophic Lateral Sclerosis (ALS) Clinical Trial Design. Neurotherapeutics 19:4, pages 1180-1192.
Crossref
Lu Tang & Dongsheng Fan. (2022) Amyotrophic lateral sclerosis: new era, new challenges. The Lancet Neurology 21:5, pages 400-401.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.